Merck & Co. (NYSE:MRK) is a prominent American multinational pharmaceutical company many investors know for its brand-name ...

Here are seven attractively valued dividend stocks investors can bet on for the long term, according to Bank of America ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Growing demand for tryptamine APIs stems from their anti-cancer potential, pharmaceutical uses, and role as a neurotransmitter modulator i ...

Commvault, a pioneering provider of cyber resilience and data protection solutions for the hybrid cloud, announced that the Commvault Cloud Platform can be easily deployed from major ...

When it comes to investing in pharmaceutical companies, looking at pipelines and research and development prospects is ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

We expect Moderna MRNA to surpass expectations when it reports fourth-quarter and full-year 2024 earnings on Feb. 14, before the opening bell. In the last reported quarter, MRNA’s earnings beat ...

ARM and Oracle are key AI bellwethers, reflecting market volatility and investor sentiment towards AI and tech stocks. Tariff threats under Trump create market uncertainty, but investors are ...